Boston, MA—January 17, 2017—LEERINK Partners, a leading healthcare investment bank, announced that Michael Marco has joined as Managing Director and Head of Equity Trading. Mr. Marco will be based in the firm’s New York office. Mr. Marco brings to LEERINK Partners over 13 years of experience in healthcare trading. Most recently, he served as Managing Director, Head of Healthcare Trading at Bank of America Merrill Lynch and was responsible for managing both customer and proprietary accounts, and risk across the entire healthcare sector. Prior to Bank of America Merrill Lynch, Mr. Marco worked in various leadership roles across the industry, including serving as a Managing Director and Head of Healthcare Trading at Credit Suisse Securities and Managing Director and Head of Execution at Leerink Swann & Company.
“We are pleased to have Mike join the firm to lead our trading effort,” said Rob Leerink, Senior Managing Director, Head of Institutional Equities. “Mike has a well-deserved reputation in healthcare trading and is a proven business leader. With his experience, knowledgeable insights and client-centric approach, I am confident that Mike will position our firm for the best possible success and we’re glad to welcome him back.”
”I am excited to be joining such a dynamic team that is solely focused on healthcare,” said Mr. Marco. “In an ever-evolving healthcare environment, LEERINK Partners is well-prepared to capitalize on industry growth and opportunity, and I look forward to being part of the team.”
About LEERINK Partners
LEERINK Partners LLC is a leading investment bank, specializing in healthcare. Our knowledge, experience and focus enable us to help our clients define and achieve their strategic, capital markets and investment objectives. We partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare. LEERINK Partners LLC is a member of FINRA/SIPC. For more information, please visit: www.leerink.com.